Supplementary Figure 2 from &lt;i&gt;In Situ&lt;/i&gt; Analysis of Mutant EGFRs Prevalent in Glioblastoma Multiforme Reveals Aberrant Dimerization, Activation, and Differential Response to Anti-EGFR Targeted Therapy